InvestorsHub Logo
icon url

Monroe1

10/09/20 1:31 PM

#122288 RE: C-20 #122287

So true the impatience of todays investors wanting a quick buck and if not then make up junk and lies with the hope of getting price action. EUA or finishing the trial either one brings the therapy drug to the public. The death delay will be at the hands of the FDA and all those that support them. For the FDA to throw up unneeded delays when they well know the science says otherwise, is criminal behavior. Some laws need to be changed. Whatever, GO leronlimab, best darn Mab there is.

https://aapsonline.org/hcqsuit/

https://www.lawyerlocator.com/mass-tort/suing-the-fda-for-approving-defective-drugs
icon url

Latane

10/09/20 1:34 PM

#122290 RE: C-20 #122287

Sorry I didn’t answer your question the other night - was out of posts. Regarding the DSMC, I don’t think people on this forum appreciate the currency used in Washington - it is power. It’s by-product is money. Resultantly, we are unlikely to get a decision on an EUA in October. Most of the bureaucratic class within the Beltway is Democratic. Just like with the Cares II Act or stand-alone Airline aid, they are holding up anything at this point that would look like a Trump win. Politicians could care less if people die ( just look at those killed in profitable, feckless never-ending war), so long as their power is sustained and results in personal profit.

I will be dumbfounded if we hear anything by next Friday, doubly so if we get an EUA recommend. I am confident we will have great results. I am completely skeptical that the FDA and the State will act on them..
icon url

studhoss

10/09/20 10:55 PM

#122414 RE: C-20 #122287

Is there any reason why they couldn't do both? They could Grant emergency use authorization but still continue the study to the end. Is that an impossible or unlikely scenario for some reason?